PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+13.59%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$11.5B
AUM Growth
+$11.5B
(+5.5%)
Cap. Flow
-$598M
Cap. Flow
% of AUM
-5.2%
Top 10 Holdings %
Top 10 Hldgs %
26.57%
Holding
326
New
47
Increased
82
Reduced
126
Closed
45
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$67.4M |
| 2 |
Zimmer Biomet
ZBH
|
$61.7M |
| 3 |
Stryker
SYK
|
$61.3M |
| 4 |
HCA Healthcare
HCA
|
$56.9M |
| 5 |
US Foods
USFD
|
$51M |
Top Sells
| 1 |
ServiceNow
NOW
|
$68.9M |
| 2 |
Expedia Group
EXPE
|
$67.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$60M |
| 4 |
Edwards Lifesciences
EW
|
$57.8M |
| 5 |
Danaher
DHR
|
$50.5M |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Financials | 22.37% |
| 3 | Healthcare | 17.75% |
| 4 | Communication Services | 10.21% |
| 5 | Consumer Discretionary | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
W.R. Berkley
WRB
$27.2B
| $82.1M | 0.71% | 1,187,500 -50,000 | -4% | -$3.45M |
|
27
Dolby
DLB
$6.87B
| $80.7M | 0.7% | 1,173,489 -609,277 | -34% | -$41.9M |
|
28
Citigroup
C
$178B
| $80.1M | 0.7% | 1,002,901 -302,518 | -23% | -$24.2M |
|
|
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $78.2M | 0.68% | 2,159,256 -98,529 | -4% | -$3.57M |
|
30
NVIDIA
NVDA
$4.24T
| $77.7M | 0.68% | 330,368 -101,209 | -23% | -$23.8M |
|
|
AYX
31
DELISTED
Alteryx, Inc.
AYX
| $77.5M | 0.67% | 774,463 +462,893 | +149% | +$46.3M |
|
32
Applied Materials
AMAT
$128B
| $74.1M | 0.64% | 1,213,184 +423,785 | +54% | +$25.9M |
|
|
33
HCA Healthcare
HCA
$94.5B
| $73.4M | 0.64% | 496,438 +385,115 | +346% | +$56.9M |
|
34
Progressive
PGR
$145B
| $70.9M | 0.62% | 980,000 +93,700 | +11% | +$6.78M |
|
35
Aon
AON
$79.1B
| $69.9M | 0.61% | 335,500 -9,500 | -3% | -$1.98M |
|
36
JPMorgan Chase
JPM
$829B
| $69.3M | 0.6% | 497,194 -181,566 | -27% | -$25.3M |
|
|
QTNT
37
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $69M | 0.6% | 7,257,319 +1,111,256 | +18% | +$10.6M |
|
38
Mastercard
MA
$538B
| $68.6M | 0.6% | 229,738 +7,171 | +3% | +$2.14M |
|
39
Travelers Companies
TRV
$61.1B
| $68.5M | 0.6% | 500,000 +20,000 | +4% | +$2.74M |
|
40
Bank of America
BAC
$376B
| $68.4M | 0.6% | 1,941,377 -854,508 | -31% | -$30.1M |
|
|
41
Bristol-Myers Squibb
BMY
$96B
| $67.4M | 0.59% | +1,050,395 | New | +$67.4M |
|
42
Uber
UBER
$196B
| $67M | 0.58% | 2,252,905 +1,286,532 | +133% | +$38.3M |
|
43
Canadian Natural Resources
CNQ
$65.9B
| $66.7M | 0.58% | 1,780,434 -569,570 | -24% | -$21.3M |
|
|
SPLK
44
DELISTED
Splunk Inc
SPLK
| $66.3M | 0.58% | 442,599 +247,731 | +127% | +$37.1M |
|
|
ANSS
45
DELISTED
Ansys
ANSS
| $65.9M | 0.57% | 255,903 -103,745 | -29% | -$26.7M |
|
|
46
Danaher
DHR
$147B
| $63.2M | 0.55% | 411,861 -328,870 | -44% | -$50.5M |
|
47
Autodesk
ADSK
$67.3B
| $62.9M | 0.55% | 342,923 -169,773 | -33% | -$31.1M |
|
48
Bio-Rad Laboratories Class A
BIO
$8.06B
| $61.9M | 0.54% | 167,410 -44,466 | -21% | -$16.5M |
|
|
49
Zimmer Biomet
ZBH
$21B
| $61.7M | 0.54% | +412,323 | New | +$61.7M |
|
50
Boston Scientific
BSX
$156B
| $61.3M | 0.53% | 1,355,195 -219,029 | -14% | -$9.9M |
|